IRIS

BRAVACCINI, SARA

BRAVACCINI, SARA  

Dipartimento di Medicina e Chirurgia  

Mostra records
Risultati 1 - 20 di 129 (tempo di esecuzione: 0.026 secondi).
Titolo Data di pubblicazione Autore(i) File
A functional survey of the regulatory landscape of estrogen-receptor-positive breast cancer evolution 1-gen-2024 Barozzi, I; Slaven, N; Canale, E; Lopes, R; Amorim Monteiro Barbosa, I; Bleu, M; Ivanoiu, D; Pacini, C; Mensa, E; Chambers, A; Bravaccini, S; Ravaioli, S; Gyorffy, B; Dieci, Mv; Pruneri, G; Galli, Gg; Magnani, L
Accuracy of urine telomerase activity to detect bladder cancer in symptomatic patients 1-gen-2009 Casadio, V; Bravaccini, S; Gunelli, R; Nanni, O; Zoli, W; Amadori, D; Calistri, D; Silvestrini, R
ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients 1-gen-2020 Ravaioli, Sara; Tebaldi, Michela; Fonzi, Eugenio; Angeli, Davide; Mazza, Massimiliano; Nicolini, Fabio; Lucchesi, Alessandro; Fanini, Francesca; Pirini, Francesca; Tumedei Maria, Maddalena; Cerchione, Claudio; Viale, Pierluigi; Sambri, Vittorio; Martinelli, Giovanni; Bravaccini, S
ALK translocation detection in non-small cell lung cancer cytological samples obtained by TBNA or EBUS-TBNA 1-gen-2016 Bravaccini, S; Tumedei, Mm; Ulivi, P; Zoli, W; Calistri, D; Candoli, P; Amadori, D; Puccetti, M
An H-1 NMR study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance in acute leukemia 1-gen-2020 Cerchione, C; Martinelli, G; Pedatella, S; De Nisco, M; Pugliese, N; Manfra, M; Marra, N; Ronconi, S; De Giorgi, U; Altini, M; Simonetti, G; Di Rora, Agl; Bravaccini, S; Catalano, L; Iula, Vd; Pagano, F; Picardi, M; Bolognese, A; Pane, F; Martinelli, V
An initiative to assess the quality of Tanzanian cervical cancer specimens for HPV and telomerase detection 1-gen-2021 Ravaioli, S; Pirini, F; Tumedei, Mm; Puccetti, M; Chiadini, E; Serra, P; Kahima, J; Masalu, N; Amadori, D; Bravaccini, S
An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 Inhibitors and Hormone Therapy 1-gen-2024 Maltoni, Roberta; Roncadori, Andrea; Balzi, William; Mazza, Massimiliano; Nicolini, Fabio; Palleschi, Michela; Ulivi, Paola; Bravaccini, Sara
Analysis of Genetic Alterations in Tunisian Patients with Lung Adenocarcinoma 1-gen-2019 Dhieb, D; Belguith, I; Capelli, L; Chiadini, E; Canale, M; Bravaccini, S; Yangui, I; Boudawara, O; Jlidi, R; Boudawara, T; Calistri, D; Keskes, La; Ulivi, P
Androgen and oestrogen receptors as potential prognostic markers for patients with ductal carcinoma insitu treated with surgery and radiotherapy 1-gen-2017 Ravaioli, S; Tumedei, Mm; Foca, F; Maltoni, R; Rocca, A; Massa, I; Pietri, E; Bravaccini, S
Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases? 1-gen-2018 Bronte, G; Bravaccini, S; Ravaioli, S; Puccetti, M; Scarpi, E; Andreis, D; Tumedei, Mm; Sarti, S; Cecconetto, L; Pietri, E; De Simone, V; Maltoni, R; Bonafe, M; Amadori, D; Rocca, A
Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy? 1-gen-2018 Bronte, Giuseppe; Rocca, Andrea; Ravaioli, Sara; Puccetti, Maurizio; Tumedei Maria, Maddalena; Scarpi, Emanuela; Andreis, Daniele; Maltoni, Roberta; Sarti, Samanta; Cecconetto, Lorenzo; Pietri, Elisabetta; De Simone, Valeria; Asioli, Silvia; Amadori, Dino; Bravaccini, S
Androgen receptor in breast cancer: A wolf in sheep's clothing? A lesson from prostate cancer 1-gen-2020 Salvi, S; Bonafe, M; Bravaccini, S
Androgen receptor in breast cancer: The "5W" questions 1-gen-2022 Ravaioli, S; Maltoni, R; Pasculli, B; Parrella, P; Giudetti, Am; Vergara, D; Tumedei, Mm; Pirini, F; Bravaccini, S
Androgen receptor signaling pathways as a target for breast cancer treatment 1-gen-2016 Pietri, E; Conteduca, V; Andreis, D; Massa, I; Melegari, E; Sarti, S; Cecconetto, L; Schirone, A; Bravaccini, S; Serra, P; Fedeli, A; Maltoni, R; Amadori, D; De Giorgi, U; Rocca, A
Appropriateness and Economic Analysis of Conventional Circulating Biomarkers Assessment in Early Breast Cancer: A Real-World Experience from the E.Pic.A Study 1-gen-2022 Maltoni, R; Balzi, W; Rossi, T; Fabbri, F; Bravaccini, S; Montella, Mt; Massa, I; Bertoni, L; Falcini, F; Altini, M
Are Androgen and Estrogen Receptors in DCIS Patients Prognostic Indicators of Relapse Independently of Treatment? 1-gen-2019 Ravaioli, S; Puccetti, M; Tumedei, Mm; Silvestrini, R; Bedei, L; Bravaccini, S
Are BMI and Negative Hormone Receptors Prognostic Factors in HER2+ Early-stage Breast Cancer? 1-gen-2020 Maltoni, R.; Palleschi, M.; Altini, M.; Massa, I.; Balzi, W.; Ravaioli, S.; Tumedei, M. M.; Rocca, A.; Bravaccini, S.
Are fine-needle aspiration biopsy-derived cell blocks a useful surrogate for tissue samples in breast cancer? 1-gen-2018 Puccetti, M; Ravaioli, S; Tumedei, Mm; Bucchi, E; Malmesi, M; Medri, L; Bravaccini, S
Are There Differences in Androgen Receptor Expression in Invasive Breast Cancer in African (Tanzanian) Population in Comparison With the Caucasian (Italian) Population? 1-gen-2018 Bravaccini, S; Ravaioli, S; Amadori, D; Scarpi, E; Puccetti, M; Rocca, A; Tumedei, Mm; Masalu, N; Kahima, J; Pangan, A; Faustine, L; Farolfi, A; Maltoni, R; Bonafe, M; Serra, P; Bronte, G
Are we ready to use TMB in breast cancer clinical practice? 1-gen-2020 Ravaioli, S.; Limarzi, F.; Tumedei, M. M.; Palleschi, M.; Maltoni, R.; Bravaccini, S.